Hyperlipoproteinemia Type Iii
📧 Sign up to get email alerts when something new happens for Hyperlipoproteinemia Type Iii.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2012-02-17Clinical Trial Update: Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Subjects With A Genetic Cholesterol Disorder. [Phase 3]
A Phase 3 clinical trial evaluating torcetrapib and atorvastatin in subjects with Hyperlipoproteinemia Type III has been terminated.